| E-Y0001503 |
EP |
【喹那普利系统适应 |
Quinapril for system suitability |
|
5.125 mg |
1264 |
28 |
| E-Y0001502 |
EP |
【喹那普利峰值鉴别 |
Quinapril for peak identification |
|
5.075 mg |
1264 |
28 |
| E-Y0001501 |
EP |
【青风藤粉末HRS（订 |
Orientvine stem HRS |
|
600 mg |
1264 |
28 |
| E-Y0001500 |
EP |
【薏苡仁HRS（订货以 |
Coix seed HRS |
|
1300 mg |
1264 |
28 |
| E-Y0001499 |
EP |
【奈韦拉平半水合物 |
Nevirapine hemihydrate |
|
15 mg |
1264 |
28 |
| E-Y0001498 |
EP |
【洛匹那韦（订货以英 |
Lopinavir |
|
200 mg |
1264 |
28 |
| E-Y0001497 |
EP |
【3-三甲基甲硅烷基 |
3-Trimethylsilyl-1-propanesulfonic acid sodium salt |
|
120 mg |
1264 |
28 |
| E-Y0001496 |
EP |
【头孢西丁峰值鉴别 |
Cefoxitin for peak identification |
|
15 mg |
1264 |
28 |
| E-Y0001495 |
EP |
【磺胺二甲嘧啶峰值 |
Sulfadimidine for peak identification |
|
50 mg |
1264 |
28 |
| E-Y0001494 |
EP |
【氢氯噻嗪峰值鉴别 |
Hydrochlorothiazide for peak identification |
|
10 mg |
1264 |
28 |
| E-Y0001493 |
EP |
【呋塞米峰值鉴别（订 |
Furosemide for peak identification |
|
10 mg |
1264 |
28 |
| E-Y0001492 |
EP |
【多西拉敏系统适应 |
Doxylamine for system suitability |
|
110 mg |
1264 |
28 |
| E-Y0001491 |
EP |
【盐酸喹那普利（订货 |
Quinapril hydrochloride |
|
30 mg |
1264 |
28 |
| E-Y0001490 |
EP |
【哌甲酯杂质C（订货 |
Methylphenidate impurity C |
|
10 mg |
1264 |
28 |
| E-Y0001489 |
EP |
【2-（二甲基氨基）乙基 |
2-(Dimethylamino)ethyl methacrylate |
|
50 mg |
1264 |
28 |
粤公网安备 44010302000979号